Skip to main content

Find Clinical Trials

Home
Conditions
EGFR Mutation-Positive Lung Cancer

Clinical trial condition

EGFR Mutation-Positive Lung Cancer

Explore clinical trials studying EGFR Mutation-Positive Lung Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

EGFR Mutation-Positive Lung Cancer trial results

Recruiting

Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study

NCT06728865

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +20 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details